Table 2

Effect of Intervention on primary and secondary outcomes by study group*

ImmunisationControl (n=300)Intervention (n=300)RR (95% CI)RD (95% CI)P value
Penta-1† n (%)289 (97)285 (95)0.98 (0.95 to 1.02)−0.02 (−0.05 to 0.015)0.31
Penta-2† n (%)278 (93)276 (92)0.99 (0.95 to 1.04)−0.01 (−0.04 to 0.05)0.76
Penta-3† n (%)244 (81)257 (86)1.05 (0.98 to 1.13)0.04 (−0.02 to 0.10)0.15
Measles‡ n (%)196 (66)220 (74)1.12 (1.01 to 1.25)0.08 (0.01 to 0.15)0.03
  • *Modified intention-to-treat analysis; includes all subjects regardless of where immunisation was received or how it was audited.

  • †Assessed at 18 weeks.

  • ‡Assessed at 12 months.

  • RD, risk difference; RR, risk ratio.